First biosafety, biodistribution and dosimetry study of the gastrin analogue In-111-CP04 in medullary thyroid cancer. Phase I clinical trial, GRANT-T-MTC

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING(2017)

Cited 0|Views16
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined